GL1X · GenesisL1 explorer

MolNFT v1 · #166210 · protein

BACE2 mutant in complex with a macrocyclic compound

6UJ1 · Beta-secretase 2: “BACE2 mutant in complex with a macrocyclic compound”. X-ray diffraction, 1 ligand (L3M), 2 pockets (best druggability 0.78). MolNFT v1 #166210 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6UJ1
Type
protein
Length
724 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 2
EC
3.4.23.45
UniProt
Q9Y5Z0
Ligands
L3M
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 14% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 2 (EC 3.4.23.45)protein36714% helix, 41% strandQ9Y5Z0
BBeta-secretase 2 (EC 3.4.23.45)protein35714% helix, 42% strandQ9Y5Z0

Ligands and binding sites

  • L3M · (3S)-3-hydroxy-N-(2-methylpropyl)-N~2~-{[(4S)-17-[(methylsulfonyl)(propyl)amino]-2-oxo-3-azatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15, 17-hexaen-4-yl]methyl}-L-norleucinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111300.780.80107L3M
2660.380.7812empty

Interfaces

1 interface between chains.

  • A–B · 454 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 6UJ1 · BACE2 mutant in complex with a macrocyclic compound · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y5Z0 · AlphaFold monomer V2.0 prediction for beta-secretase 2 (Q9Y5Z0) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.